<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32640422</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>04</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1945-4589</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>14</Issue><PubDate><Year>2020</Year><Month>Jul</Month><Day>08</Day></PubDate></JournalIssue><Title>Aging</Title><ISOAbbreviation>Aging (Albany NY)</ISOAbbreviation></Journal><ArticleTitle>Signatures of cell stress and altered bioenergetics in skin fibroblasts from patients with multiple sclerosis.</ArticleTitle><Pagination><StartPage>15134</StartPage><EndPage>15156</EndPage><MedlinePgn>15134-15156</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.18632/aging.103612</ELocationID><Abstract><AbstractText>Multiple sclerosis (MS) is a central nervous system inflammatory demyelinating disease and the most common cause of non-traumatic disability in young adults. Despite progress in the treatment of the active relapsing disease, therapeutic options targeting irreversible progressive decline remain limited. Studies using skin fibroblasts derived from patients with neurodegenerative disorders demonstrate that cell stress pathways and bioenergetics are altered when compared to healthy individuals. However, findings in MS skin fibroblasts are limited. Here, we collected skin fibroblasts from 24 healthy control individuals, 30 patients with MS, and ten with amyotrophic lateral sclerosis (ALS) to investigate altered cell stress profiles. We observed endoplasmic reticulum swelling in MS skin fibroblasts, and increased gene expression of cell stress markers including <i>BIP</i>, <i>ATF4</i>, <i>CHOP</i>, <i>GRP94</i>, <i>P53</i>, and <i>P21</i>. When challenged against hydrogen peroxide, MS skin fibroblasts had reduced resiliency compared to ALS and controls. Mitochondrial and glycolytic functions were perturbed in MS skin fibroblasts while exhibiting a significant increase in lactate production over ALS and controls. Our results suggest that MS skin fibroblasts have an underlying stress phenotype, which may be disease specific. Interrogating MS skin fibroblasts may provide patient specific molecular insights and aid in prognosis, diagnosis, and therapeutic testing enhancing individualized medicine.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wilkins</LastName><ForeName>Jordan M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gakh</LastName><ForeName>Oleksandr</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kabiraj</LastName><ForeName>Parijat</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCarthy</LastName><ForeName>Christina B</ForeName><Initials>CB</Initials><AffiliationInfo><Affiliation>Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tobin</LastName><ForeName>W Oliver</ForeName><Initials>WO</Initials><AffiliationInfo><Affiliation>Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Howe</LastName><ForeName>Charles L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology, Mayo Clinic, Rochester, MN 55905, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN 55905, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lucchinetti</LastName><ForeName>Claudia F</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Aging (Albany NY)</MedlineTA><NlmUniqueID>101508617</NlmUniqueID><ISSNLinking>1945-4589</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C497109">ATF4 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C497249">DDIT3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C053387">endoplasmin</NameOfSubstance></Chemical><Chemical><RegistryNumber>145891-90-3</RegistryNumber><NameOfSubstance UI="D051701">Activating Transcription Factor 4</NameOfSubstance></Chemical><Chemical><RegistryNumber>147336-12-7</RegistryNumber><NameOfSubstance UI="D051742">Transcription Factor CHOP</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Aging (Albany NY). 2021 Mar 3;13(5):7707</RefSource><PMID Version="1">33657013</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D051701" MajorTopicYN="N">Activating Transcription Factor 4</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073537" MajorTopicYN="N">Biological Variation, Population</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004721" MajorTopicYN="Y">Endoplasmic Reticulum</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004734" MajorTopicYN="N">Energy Metabolism</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D028361" MajorTopicYN="N">Mitochondrial Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="Y">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057285" MajorTopicYN="N">Precision Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012867" MajorTopicYN="N">Skin</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051742" MajorTopicYN="N">Transcription Factor CHOP</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">bioenergetics</Keyword><Keyword MajorTopicYN="N">cellular stress</Keyword><Keyword MajorTopicYN="N">metabolism</Keyword><Keyword MajorTopicYN="N">multiple sclerosis</Keyword><Keyword MajorTopicYN="N">skin fibroblasts</Keyword></KeywordList><CoiStatement><b>CONFLICTS OF INTEREST:</b> The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32640422</ArticleId><ArticleId IdType="pmc">PMC7425440</ArticleId><ArticleId IdType="doi">10.18632/aging.103612</ArticleId><ArticleId IdType="pii">103612</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ransohoff RM, Hafler DA, Lucchinetti CF. Multiple sclerosis-a quiet revolution. Nat Rev Neurol. 2015; 11:134&#x2013;42. 10.1038/nrneurol.2015.14</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2015.14</ArticleId><ArticleId IdType="pmc">PMC4556342</ArticleId><ArticleId IdType="pubmed">25686758</ArticleId></ArticleIdList></Reference><Reference><Citation>Baranzini SE, Oksenberg JR. The genetics of multiple sclerosis: from 0 to 200 in 50 years. Trends Genet. 2017; 33:960&#x2013;70. 10.1016/j.tig.2017.09.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2017.09.004</ArticleId><ArticleId IdType="pmc">PMC5701819</ArticleId><ArticleId IdType="pubmed">28987266</ArticleId></ArticleIdList></Reference><Reference><Citation>Hipp MS, Kasturi P, Hartl FU. The proteostasis network and its decline in ageing. Nat Rev Mol Cell Biol. 2019; 20:421&#x2013;35. 10.1038/s41580-019-0101-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-019-0101-y</ArticleId><ArticleId IdType="pubmed">30733602</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou Y, Dan X, Babbar M, Wei Y, Hasselbalch SG, Croteau DL, Bohr VA. Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol. 2019; 15:565&#x2013;81. 10.1038/s41582-019-0244-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-019-0244-7</ArticleId><ArticleId IdType="pubmed">31501588</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf8;gest&#xf8;l EA, Kaufmann T, Nygaard GO, Beyer MK, Sowa P, Nordvik JE, Kolsk&#xe5;r K, Richard G, Andreassen OA, Harbo HF, Westlye LT. Cross-sectional and longitudinal MRI brain scans reveal accelerated brain aging in multiple sclerosis. Front Neurol. 2019; 10:450. 10.3389/fneur.2019.00450</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00450</ArticleId><ArticleId IdType="pmc">PMC6503038</ArticleId><ArticleId IdType="pubmed">31114541</ArticleId></ArticleIdList></Reference><Reference><Citation>Albanese M, Zagaglia S, Landi D, Boffa L, Nicoletti CG, Marciani MG, Mandolesi G, Marfia GA, Buttari F, Mori F, Centonze D. Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression. J Neuroinflammation. 2016; 13:36. 10.1186/s12974-016-0502-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0502-1</ArticleId><ArticleId IdType="pmc">PMC4750170</ArticleId><ArticleId IdType="pubmed">26863878</ArticleId></ArticleIdList></Reference><Reference><Citation>Mh&#xe1;ille AN, McQuaid S, Windebank A, Cunnea P, McMahon J, Samali A, FitzGerald U. Increased expression of endoplasmic reticulum stress-related signaling pathway molecules in multiple sclerosis lesions. J Neuropathol Exp Neurol. 2008; 67:200&#x2013;11. 10.1097/NEN.0b013e318165b239</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e318165b239</ArticleId><ArticleId IdType="pubmed">18344911</ArticleId></ArticleIdList></Reference><Reference><Citation>Wentling M, Lopez-Gomez C, Park HJ, Amatruda M, Ntranos A, Aramini J, Petracca M, Rusielewicz T, Chen E, Tolstikov V, Kiebish M, Fossati V, Inglese M, et al.. A metabolic perspective on CSF-mediated neurodegeneration in multiple sclerosis. Brain. 2019; 142:2756&#x2013;74. 10.1093/brain/awz201</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz201</ArticleId><ArticleId IdType="pubmed">31305892</ArticleId></ArticleIdList></Reference><Reference><Citation>Way SW, Popko B. Harnessing the integrated stress response for the treatment of multiple sclerosis. Lancet Neurol. 2016; 15:434&#x2013;43. 10.1016/S1474-4422(15)00381-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(15)00381-6</ArticleId><ArticleId IdType="pmc">PMC4792730</ArticleId><ArticleId IdType="pubmed">26873788</ArticleId></ArticleIdList></Reference><Reference><Citation>Oost W, Talma N, Meilof JF, Laman JD. Targeting senescence to delay progression of multiple sclerosis. J Mol Med (Berl). 2018; 96:1153&#x2013;66. 10.1007/s00109-018-1686-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-018-1686-x</ArticleId><ArticleId IdType="pmc">PMC6208951</ArticleId><ArticleId IdType="pubmed">30229272</ArticleId></ArticleIdList></Reference><Reference><Citation>Reich DS, Lucchinetti CF, Calabresi PA. Multiple sclerosis. N Engl J Med. 2018; 378:169&#x2013;80. 10.1056/NEJMra1401483</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1401483</ArticleId><ArticleId IdType="pmc">PMC6942519</ArticleId><ArticleId IdType="pubmed">29320652</ArticleId></ArticleIdList></Reference><Reference><Citation>Mincu RI, Magda SL, Mihaila S, Florescu M, Mihalcea DJ, Velcea A, Chiru A, Tiu C, Popescu BO, Cinteza M, Vinereanu D. Impaired cardiac function in patients with multiple sclerosis by comparison with normal subjects. Sci Rep. 2018; 8:3300. 10.1038/s41598-018-21599-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-21599-0</ArticleId><ArticleId IdType="pmc">PMC5818507</ArticleId><ArticleId IdType="pubmed">29459794</ArticleId></ArticleIdList></Reference><Reference><Citation>Wens I, Dalgas U, Vandenabeele F, Krekels M, Grevendonk L, Eijnde BO. Multiple sclerosis affects skeletal muscle characteristics. PLoS One. 2014; 9:e108158. 10.1371/journal.pone.0108158</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0108158</ArticleId><ArticleId IdType="pmc">PMC4180259</ArticleId><ArticleId IdType="pubmed">25264868</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebregiworgis T, Nielsen HH, Massilamany C, Gangaplara A, Reddy J, Illes Z, Powers R. A urinary metabolic signature for multiple sclerosis and neuromyelitis optica. J Proteome Res. 2016; 15:659&#x2013;66. 10.1021/acs.jproteome.5b01111</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.5b01111</ArticleId><ArticleId IdType="pmc">PMC4772670</ArticleId><ArticleId IdType="pubmed">26759122</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Ambrosio A, Pontecorvo S, Colasanti T, Zamboni S, Francia A, Margutti P. Peripheral blood biomarkers in multiple sclerosis. Autoimmun Rev. 2015; 14:1097&#x2013;110. 10.1016/j.autrev.2015.07.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2015.07.014</ArticleId><ArticleId IdType="pubmed">26226413</ArticleId></ArticleIdList></Reference><Reference><Citation>Amorini AM, Nociti V, Petzold A, Gasperini C, Quartuccio E, Lazzarino G, Di Pietro V, Belli A, Signoretti S, Vagnozzi R, Lazzarino G, Tavazzi B. Serum lactate as a novel potential biomarker in multiple sclerosis. Biochim Biophys Acta. 2014; 1842:1137&#x2013;43. 10.1016/j.bbadis.2014.04.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2014.04.005</ArticleId><ArticleId IdType="pubmed">24726946</ArticleId></ArticleIdList></Reference><Reference><Citation>Konrad C, Kawamata H, Bredvik KG, Arreguin AJ, Cajamarca SA, Hupf JC, Ravits JM, Miller TM, Maragakis NJ, Hales CM, Glass JD, Gross S, Mitsumoto H, Manfredi G. Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients. Mol Neurodegener. 2017; 12:76. 10.1186/s13024-017-0217-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-017-0217-5</ArticleId><ArticleId IdType="pmc">PMC5655870</ArticleId><ArticleId IdType="pubmed">29065921</ArticleId></ArticleIdList></Reference><Reference><Citation>Teves JM, Bhargava V, Kirwan KR, Corenblum MJ, Justiniano R, Wondrak GT, Anandhan A, Flores AJ, Schipper DA, Khalpey Z, Sligh JE, Curiel-Lewandrowski C, Sherman SJ, Madhavan L. Parkinson&#x2019;s disease skin fibroblasts display signature alterations in growth, redox homeostasis, mitochondrial function, and autophagy. Front Neurosci. 2018; 11:737. 10.3389/fnins.2017.00737</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2017.00737</ArticleId><ArticleId IdType="pmc">PMC5770791</ArticleId><ArticleId IdType="pubmed">29379409</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#x119;drak P, Mozolewski P, W&#x119;grzyn G, Wi&#x119;ckowski MR. Mitochondrial alterations accompanied by oxidative stress conditions in skin fibroblasts of Huntington&#x2019;s disease patients. Metab Brain Dis. 2018; 33:2005&#x2013;17. 10.1007/s11011-018-0308-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11011-018-0308-1</ArticleId><ArticleId IdType="pmc">PMC6244791</ArticleId><ArticleId IdType="pubmed">30120672</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez MJ, Ponce DP, Osorio-Fuentealba C, Behrens MI, Quintanilla RA. Mitochondrial bioenergetics is altered in fibroblasts from patients with sporadic Alzheimer&#x2019;s disease. Front Neurosci. 2017; 11:553. 10.3389/fnins.2017.00553</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2017.00553</ArticleId><ArticleId IdType="pmc">PMC5635042</ArticleId><ArticleId IdType="pubmed">29056898</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan TK, Sen A, Hongpaisan J, Lim CS, Nelson TJ, Alkon DL. PKC&#x3b5; deficits in Alzheimer&#x2019;s disease brains and skin fibroblasts. J Alzheimers Dis. 2015; 43:491&#x2013;509. 10.3233/JAD-141221</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-141221</ArticleId><ArticleId IdType="pubmed">25125477</ArticleId></ArticleIdList></Reference><Reference><Citation>Joachim CL, Mori H, Selkoe DJ. Amyloid beta-protein deposition in tissues other than brain in Alzheimer&#x2019;s disease. Nature. 1989; 341:226&#x2013;30. 10.1038/341226a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/341226a0</ArticleId><ArticleId IdType="pubmed">2528696</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston JA, Cowburn RF, Norgren S, Wiehager B, Venizelos N, Winblad B, Vigo-Pelfrey C, Schenk D, Lannfelt L, O&#x2019;Neill C. Increased beta-amyloid release and levels of amyloid precursor protein (APP) in fibroblast cell lines from family members with the Swedish Alzheimer&#x2019;s disease APP670/671 mutation. FEBS Lett. 1994; 354:274&#x2013;78. 10.1016/0014-5793(94)01137-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-5793(94)01137-0</ArticleId><ArticleId IdType="pubmed">7957938</ArticleId></ArticleIdList></Reference><Reference><Citation>Szelechowski M, Amoedo N, Obre E, L&#xe9;ger C, Allard L, Bonneu M, Claverol S, Lacombe D, Oliet S, Chevallier S, Le Masson G, Rossignol R. Metabolic reprogramming in amyotrophic lateral sclerosis. Sci Rep. 2018; 8:3953. 10.1038/s41598-018-22318-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-22318-5</ArticleId><ArticleId IdType="pmc">PMC5834494</ArticleId><ArticleId IdType="pubmed">29500423</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirk K, Gennings C, Hupf JC, Tadesse S, D&#x2019;Aurelio M, Kawamata H, Valsecchi F, Mitsumoto H, Manfredi G, and ALS/PLS COSMOS Study Groups. Bioenergetic markers in skin fibroblasts of sporadic amyotrophic lateral sclerosis and progressive lateral sclerosis patients. Ann Neurol. 2014; 76:620&#x2013;24. 10.1002/ana.24244</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24244</ArticleId><ArticleId IdType="pmc">PMC4192005</ArticleId><ArticleId IdType="pubmed">25090982</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernales S, McDonald KL, Walter P. Autophagy counterbalances endoplasmic reticulum expansion during the unfolded protein response. PLoS Biol. 2006; 4:e423. 10.1371/journal.pbio.0040423</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.0040423</ArticleId><ArticleId IdType="pmc">PMC1661684</ArticleId><ArticleId IdType="pubmed">17132049</ArticleId></ArticleIdList></Reference><Reference><Citation>van Deursen JM. The role of senescent cells in ageing. Nature. 2014; 509:439&#x2013;46. 10.1038/nature13193</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13193</ArticleId><ArticleId IdType="pmc">PMC4214092</ArticleId><ArticleId IdType="pubmed">24848057</ArticleId></ArticleIdList></Reference><Reference><Citation>Haronikova L, Olivares-Illana V, Wang L, Karakostis K, Chen S, F&#xe5;hraeus R. The p53 mRNA: an integral part of the cellular stress response. Nucleic Acids Res. 2019; 47:3257&#x2013;71. 10.1093/nar/gkz124</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz124</ArticleId><ArticleId IdType="pmc">PMC6468297</ArticleId><ArticleId IdType="pubmed">30828720</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker DJ, Petersen RC. Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives. J Clin Invest. 2018; 128:1208&#x2013;16. 10.1172/JCI95145</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI95145</ArticleId><ArticleId IdType="pmc">PMC5873891</ArticleId><ArticleId IdType="pubmed">29457783</ArticleId></ArticleIdList></Reference><Reference><Citation>Tacutu R, Budovsky A, Yanai H, Fraifeld VE. Molecular links between cellular senescence, longevity and age-related diseases - a systems biology perspective. Aging (Albany NY). 2011; 3:1178&#x2013;91. 10.18632/aging.100413</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.100413</ArticleId><ArticleId IdType="pmc">PMC3273898</ArticleId><ArticleId IdType="pubmed">22184282</ArticleId></ArticleIdList></Reference><Reference><Citation>Childs BG, Durik M, Baker DJ, van Deursen JM. Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat Med. 2015; 21:1424&#x2013;35. 10.1038/nm.4000</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4000</ArticleId><ArticleId IdType="pmc">PMC4748967</ArticleId><ArticleId IdType="pubmed">26646499</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicaise AM, Wagstaff LJ, Willis CM, Paisie C, Chandok H, Robson P, Fossati V, Williams A, Crocker SJ. Cellular senescence in progenitor cells contributes to diminished remyelination potential in progressive multiple sclerosis. Proc Natl Acad Sci USA. 2019; 116:9030&#x2013;39. 10.1073/pnas.1818348116</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1818348116</ArticleId><ArticleId IdType="pmc">PMC6500153</ArticleId><ArticleId IdType="pubmed">30910981</ArticleId></ArticleIdList></Reference><Reference><Citation>Kritsilis M, V Rizou S, Koutsoudaki PN, Evangelou K, Gorgoulis VG, Papadopoulos D. Ageing, cellular senescence and neurodegenerative disease. Int J Mol Sci. 2018; 19:2937. 10.3390/ijms19102937</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19102937</ArticleId><ArticleId IdType="pmc">PMC6213570</ArticleId><ArticleId IdType="pubmed">30261683</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, You L, Xue J, Lu Y. Ionizing radiation-induced cellular senescence in normal, non-transformed cells and the involved DNA damage response: a mini review. Front Pharmacol. 2018; 9:522. 10.3389/fphar.2018.00522</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2018.00522</ArticleId><ArticleId IdType="pmc">PMC5972185</ArticleId><ArticleId IdType="pubmed">29872395</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharpless NE, Sherr CJ. Forging a signature of in vivo senescence. Nat Rev Cancer. 2015; 15:397&#x2013;408. 10.1038/nrc3960</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc3960</ArticleId><ArticleId IdType="pubmed">26105537</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahad DH, Trapp BD, Lassmann H. Pathological mechanisms in progressive multiple sclerosis. Lancet Neurol. 2015; 14:183&#x2013;93. 10.1016/S1474-4422(14)70256-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70256-X</ArticleId><ArticleId IdType="pubmed">25772897</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassmann H, van Horssen J. Oxidative stress and its impact on neurons and glia in multiple sclerosis lesions. Biochim Biophys Acta. 2016; 1862:506&#x2013;10. 10.1016/j.bbadis.2015.09.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2015.09.018</ArticleId><ArticleId IdType="pubmed">26432481</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Adachi M, Zhao S, Hareyama M, Koong AC, Luo D, Rando TA, Imai K, Shinomura Y. Preventing oxidative stress: a new role for XBP1. Cell Death Differ. 2009; 16:847&#x2013;57. 10.1038/cdd.2009.14</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2009.14</ArticleId><ArticleId IdType="pmc">PMC2826168</ArticleId><ArticleId IdType="pubmed">19247368</ArticleId></ArticleIdList></Reference><Reference><Citation>Berridge MV, Tan AS. Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch Biochem Biophys. 1993; 303:474&#x2013;82. 10.1006/abbi.1993.1311</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/abbi.1993.1311</ArticleId><ArticleId IdType="pubmed">8390225</ArticleId></ArticleIdList></Reference><Reference><Citation>Riss T, Niles A, Moravec R, Karassina N, Vidugiriene J. Cytotoxicity Assays: In Vitro Methods to Measure Dead Cells. 2019. May 1. In: Sittampalam GS, Grossman A, Brimacombe K, Arkin M, Auld D, Austin CP, Baell J, Bejcek B, Caaveiro JMM, Chung TDY, Coussens NP, Dahlin JL, Devanaryan V, Foley TL, Glicksman M, Hall MD, et al., editors. Assay Guidance Manual [Internet]. Bethesda (MD): Eli Lilly &amp; Company and the National Center for Advancing Translational Sciences; 2004.</Citation></Reference><Reference><Citation>Metallo CM, Vander Heiden MG. Understanding metabolic regulation and its influence on cell physiology. Mol Cell. 2013; 49:388&#x2013;98. 10.1016/j.molcel.2013.01.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2013.01.018</ArticleId><ArticleId IdType="pmc">PMC3569837</ArticleId><ArticleId IdType="pubmed">23395269</ArticleId></ArticleIdList></Reference><Reference><Citation>Barcelos IP, Troxell RM, Graves JS. Mitochondrial dysfunction and multiple sclerosis. Biology (Basel). 2019; 8:37. 10.3390/biology8020037</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology8020037</ArticleId><ArticleId IdType="pmc">PMC6627385</ArticleId><ArticleId IdType="pubmed">31083577</ArticleId></ArticleIdList></Reference><Reference><Citation>Adiele RC, Adiele CA. Metabolic defects in multiple sclerosis. Mitochondrion. 2019; 44:7&#x2013;14. 10.1016/j.mito.2017.12.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2017.12.005</ArticleId><ArticleId IdType="pubmed">29246870</ArticleId></ArticleIdList></Reference><Reference><Citation>Divakaruni AS, Paradyse A, Ferrick DA, Murphy AN, Jastroch M. Analysis and interpretation of microplate-based oxygen consumption and pH data. Methods Enzymol. 2014; 547:309&#x2013;54. 10.1016/B978-0-12-801415-8.00016-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-801415-8.00016-3</ArticleId><ArticleId IdType="pubmed">25416364</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackburn PR, Gass JM, Vairo FP, Farnham KM, Atwal HK, Macklin S, Klee EW, Atwal PS. Maple syrup urine disease: mechanisms and management. Appl Clin Genet. 2017; 10:57&#x2013;66. 10.2147/TACG.S125962</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/TACG.S125962</ArticleId><ArticleId IdType="pmc">PMC5593394</ArticleId><ArticleId IdType="pubmed">28919799</ArticleId></ArticleIdList></Reference><Reference><Citation>Disanto G, Berlanga AJ, Handel AE, Para AE, Burrell AM, Fries A, Handunnetthi L, De Luca GC, Morahan JM. Heterogeneity in multiple sclerosis: scratching the surface of a complex disease. Autoimmune Dis. 2010; 2011:932351. 10.4061/2011/932351</Citation><ArticleIdList><ArticleId IdType="doi">10.4061/2011/932351</ArticleId><ArticleId IdType="pmc">PMC3005811</ArticleId><ArticleId IdType="pubmed">21197462</ArticleId></ArticleIdList></Reference><Reference><Citation>Schr&#xf6;der M, Kaufman RJ. The mammalian unfolded protein response. Annu Rev Biochem. 2005; 74:739&#x2013;89. 10.1146/annurev.biochem.73.011303.074134</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.biochem.73.011303.074134</ArticleId><ArticleId IdType="pubmed">15952902</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu G, Lee AS. Role of the unfolded protein response, GRP78 and GRP94 in organ homeostasis. J Cell Physiol. 2015; 230:1413&#x2013;20. 10.1002/jcp.24923</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.24923</ArticleId><ArticleId IdType="pmc">PMC4725317</ArticleId><ArticleId IdType="pubmed">25546813</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiramatsu N, Messah C, Han J, LaVail MM, Kaufman RJ, Lin JH. Translational and posttranslational regulation of XIAP by eIF2&#x3b1; and ATF4 promotes ER stress-induced cell death during the unfolded protein response. Mol Biol Cell. 2014; 25:1411&#x2013;20. 10.1091/mbc.E13-11-0664</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E13-11-0664</ArticleId><ArticleId IdType="pmc">PMC4004591</ArticleId><ArticleId IdType="pubmed">24623724</ArticleId></ArticleIdList></Reference><Reference><Citation>Grootjans J, Kaser A, Kaufman RJ, Blumberg RS. The unfolded protein response in immunity and inflammation. Nat Rev Immunol. 2016; 16:469&#x2013;84. 10.1038/nri.2016.62</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2016.62</ArticleId><ArticleId IdType="pmc">PMC5310224</ArticleId><ArticleId IdType="pubmed">27346803</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraus A, Michalak M. Endoplasmic reticulum quality control and dysmyelination. Biomol Concepts. 2011; 2:261&#x2013;74. 10.1515/bmc.2011.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/bmc.2011.028</ArticleId><ArticleId IdType="pubmed">25962034</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin W, Bailey SL, Ho H, Harding HP, Ron D, Miller SD, Popko B. The integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage. J Clin Invest. 2007; 117:448&#x2013;56. 10.1172/JCI29571</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI29571</ArticleId><ArticleId IdType="pmc">PMC1783809</ArticleId><ArticleId IdType="pubmed">17273557</ArticleId></ArticleIdList></Reference><Reference><Citation>Roussel BD, Kruppa AJ, Miranda E, Crowther DC, Lomas DA, Marciniak SJ. Endoplasmic reticulum dysfunction in neurological disease. Lancet Neurol. 2013; 12:105&#x2013;18. 10.1016/S1474-4422(12)70238-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(12)70238-7</ArticleId><ArticleId IdType="pubmed">23237905</ArticleId></ArticleIdList></Reference><Reference><Citation>Karamita M, Nicholas R, Kokoti L, Rizou S, Mitsikostas DD, Gorgoulis V, Probert L, Papadopoulos D. Cellular Senescence Correlates with Demyelination, Brain Atrophy and Motor Impairment in a Model of Multiple Sclerosis (P2.405). Neurology. 2018; 90:P2.405.</Citation></Reference><Reference><Citation>Ohl K, Tenbrock K, Kipp M. Oxidative stress in multiple sclerosis: central and peripheral mode of action. Exp Neurol. 2016; 277:58&#x2013;67. 10.1016/j.expneurol.2015.11.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.11.010</ArticleId><ArticleId IdType="pmc">PMC7094520</ArticleId><ArticleId IdType="pubmed">26626971</ArticleId></ArticleIdList></Reference><Reference><Citation>Sprenkle NT, Sims SG, S&#xe1;nchez CL, Meares GP. Endoplasmic reticulum stress and inflammation in the central nervous system. Mol Neurodegener. 2017; 12:42. 10.1186/s13024-017-0183-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-017-0183-y</ArticleId><ArticleId IdType="pmc">PMC5445486</ArticleId><ArticleId IdType="pubmed">28545479</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiley CD, Campisi J. From ancient pathways to aging cells-connecting metabolism and cellular senescence. Cell Metab. 2016; 23:1013&#x2013;21. 10.1016/j.cmet.2016.05.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2016.05.010</ArticleId><ArticleId IdType="pmc">PMC4911819</ArticleId><ArticleId IdType="pubmed">27304503</ArticleId></ArticleIdList></Reference><Reference><Citation>Peruzzotti-Jametti L, Pluchino S. Targeting mitochondrial metabolism in neuroinflammation: towards a therapy for progressive multiple sclerosis. Trends Mol Med. 2018; 24:838&#x2013;55. 10.1016/j.molmed.2018.07.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2018.07.007</ArticleId><ArticleId IdType="pubmed">30100517</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaber T, Strehl C, Buttgereit F. Metabolic regulation of inflammation. Nat Rev Rheumatol. 2017; 13:267&#x2013;79. 10.1038/nrrheum.2017.37</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2017.37</ArticleId><ArticleId IdType="pubmed">28331208</ArticleId></ArticleIdList></Reference><Reference><Citation>Tannahill GM, Iraci N, Gaude E, Frezza C, Pluchino S. Metabolic reprograming of mononuclear phagocytes in progressive multiple sclerosis. Front Immunol. 2015; 6:106. 10.3389/fimmu.2015.00106</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2015.00106</ArticleId><ArticleId IdType="pmc">PMC4356156</ArticleId><ArticleId IdType="pubmed">25814990</ArticleId></ArticleIdList></Reference><Reference><Citation>Klotz L, Eschborn M, Lindner M, Liebmann M, Herold M, Janoschka C, Torres Garrido B, Schulte-Mecklenbeck A, Gross CC, Breuer J, Hundehege P, Posevitz V, Pignolet B, et al.. Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects. Sci Transl Med. 2019; 11:eaao5563. 10.1126/scitranslmed.aao5563</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aao5563</ArticleId><ArticleId IdType="pubmed">31043571</ArticleId></ArticleIdList></Reference><Reference><Citation>Mooney BP, Miernyk JA, Randall DD. The complex fate of alpha-ketoacids. Annu Rev Plant Biol. 2002; 53:357&#x2013;75. 10.1146/annurev.arplant.53.100301.135251</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.arplant.53.100301.135251</ArticleId><ArticleId IdType="pubmed">12221980</ArticleId></ArticleIdList></Reference><Reference><Citation>Bridi R, Braun CA, Zorzi GK, Wannmacher CM, Wajner M, Lissi EG, Dutra-Filho CS. Alpha-keto acids accumulating in maple syrup urine disease stimulate lipid peroxidation and reduce antioxidant defences in cerebral cortex from young rats. Metab Brain Dis. 2005; 20:155&#x2013;67. 10.1007/s11011-005-4152-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11011-005-4152-8</ArticleId><ArticleId IdType="pubmed">15938133</ArticleId></ArticleIdList></Reference><Reference><Citation>Funchal C, Latini A, Jacques-Silva MC, Dos Santos AQ, Buzin L, Gottfried C, Wajner M, Pessoa-Pureur R. Morphological alterations and induction of oxidative stress in glial cells caused by the branched-chain alpha-keto acids accumulating in maple syrup urine disease. Neurochem Int. 2006; 49:640&#x2013;50. 10.1016/j.neuint.2006.05.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2006.05.007</ArticleId><ArticleId IdType="pubmed">16822590</ArticleId></ArticleIdList></Reference><Reference><Citation>Jan W, Zimmerman RA, Wang ZJ, Berry GT, Kaplan PB, Kaye EM. MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation. Neuroradiology. 2003; 45:393&#x2013;99. 10.1007/s00234-003-0955-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00234-003-0955-7</ArticleId><ArticleId IdType="pubmed">12736767</ArticleId></ArticleIdList></Reference><Reference><Citation>Yudkoff M, Daikhin Y, Nissim I, Horyn O, Luhovyy B, Luhovyy B, Lazarow A, Nissim I. Brain amino acid requirements and toxicity: the example of leucine. J Nutr. 2005; 135:1531S&#x2013;8S. 10.1093/jn/135.6.1531S</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jn/135.6.1531S</ArticleId><ArticleId IdType="pubmed">15930465</ArticleId></ArticleIdList></Reference><Reference><Citation>Kane DA. Lactate oxidation at the mitochondria: a lactate-malate-aspartate shuttle at work. Front Neurosci. 2014; 8:366. 10.3389/fnins.2014.00366</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2014.00366</ArticleId><ArticleId IdType="pmc">PMC4243568</ArticleId><ArticleId IdType="pubmed">25505376</ArticleId></ArticleIdList></Reference><Reference><Citation>Harjes U. Metabolism: more lactate, please. Nat Rev Cancer. 2017; 17:707. 10.1038/nrc.2017.101</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc.2017.101</ArticleId><ArticleId IdType="pubmed">29077692</ArticleId></ArticleIdList></Reference><Reference><Citation>Tauffenberger A, Fiumelli H, Almustafa S, Magistretti PJ. Lactate and pyruvate promote oxidative stress resistance through hormetic ROS signaling. Cell Death Dis. 2019; 10:653. 10.1038/s41419-019-1877-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-019-1877-6</ArticleId><ArticleId IdType="pmc">PMC6737085</ArticleId><ArticleId IdType="pubmed">31506428</ArticleId></ArticleIdList></Reference><Reference><Citation>Zelenka J, Dvo&#x159;&#xe1;k A, Al&#xe1;n L. L-lactate protects skin fibroblasts against aging-associated mitochondrial dysfunction via mitohormesis. Oxid Med Cell Longev. 2015; 2015:351698. 10.1155/2015/351698</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/351698</ArticleId><ArticleId IdType="pmc">PMC4478408</ArticleId><ArticleId IdType="pubmed">26171114</ArticleId></ArticleIdList></Reference><Reference><Citation>Latham T, Mackay L, Sproul D, Karim M, Culley J, Harrison DJ, Hayward L, Langridge-Smith P, Gilbert N, Ramsahoye BH. Lactate, a product of glycolytic metabolism, inhibits histone deacetylase activity and promotes changes in gene expression. Nucleic Acids Res. 2012; 40:4794&#x2013;803. 10.1093/nar/gks066</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks066</ArticleId><ArticleId IdType="pmc">PMC3367171</ArticleId><ArticleId IdType="pubmed">22323521</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoque R, Farooq A, Ghani A, Gorelick F, Mehal WZ. Lactate reduces liver and pancreatic injury in toll-like receptor- and inflammasome-mediated inflammation via GPR81-mediated suppression of innate immunity. Gastroenterology. 2014; 146:1763&#x2013;74. 10.1053/j.gastro.2014.03.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2014.03.014</ArticleId><ArticleId IdType="pmc">PMC4104305</ArticleId><ArticleId IdType="pubmed">24657625</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S, Zhang KY, Kariawasam R, Bax M, Fifita JA, Ooi L, Yerbury JJ, Nicholson GA, Blair IP. Evaluation of skin fibroblasts from amyotrophic lateral sclerosis patients for the rapid study of pathological features. Neurotox Res. 2015; 28:138&#x2013;46. 10.1007/s12640-015-9532-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12640-015-9532-1</ArticleId><ArticleId IdType="pubmed">26013250</ArticleId></ArticleIdList></Reference><Reference><Citation>Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods. 2001; 25:402&#x2013;08. 10.1006/meth.2001.1262</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/meth.2001.1262</ArticleId><ArticleId IdType="pubmed">11846609</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>